Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
Geron (NASDAQ:GERN) Stock Price Up 6.1%
05:58pm, Friday, 19'th Nov 2021 Transcript Daily
Shares of Geron Co. (NASDAQ:GERN) rose 6.1% during mid-day trading on Friday . The company traded as high as $1.57 and last traded at $1.56. Approximately 20,495 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 4,293,333 shares. The stock had previously closed at $1.47. GERN has been []
B. Riley Equities Analysts Increase Earnings Estimates for Geron Co. (NASDAQ:GERN)
01:20pm, Wednesday, 17'th Nov 2021 Dakota Financial News
Geron Co. (NASDAQ:GERN) – Analysts at B. Riley raised their FY2021 earnings estimates for Geron in a note issued to investors on Monday, November 15th. B. Riley analyst J. Walsh now forecasts that the biopharmaceutical company will earn ($0.34) per share for the year, up from their prior forecast of ($0.36). B. Riley also issued […]
687,373 Shares in Geron Co. (NASDAQ:GERN) Acquired by Virtu Financial LLC
03:38pm, Sunday, 14'th Nov 2021 Transcript Daily
Virtu Financial LLC bought a new position in shares of Geron Co. (NASDAQ:GERN) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 687,373 shares of the biopharmaceutical companys stock, valued at approximately $969,000. Virtu Financial LLC owned about 0.21% of []
Geron to Present at the Stifel 2021 Virtual Healthcare Conference
07:30am, Friday, 12'th Nov 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignanci
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates
10:06pm, Tuesday, 09'th Nov 2021
Geron (GERN) delivered earnings and revenue surprises of 11.11% and 9.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175%
03:24pm, Tuesday, 02'nd Nov 2021
Some of the best penny stocks 2021 has offered were some of… The post 5 Penny Stocks To Buy According To Analysts & Price Targets Up To 175% appeared first on Penny Stocks to Buy, Picks, News and In
3 Hot Penny Stocks to Watch in November 2021
04:53pm, Tuesday, 26'th Oct 2021
Which penny stocks are on your November 2021 watchlist? The post 3 Hot Penny Stocks to Watch in November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Geron: Still A Strong Buy After New Phase II Data And 20% Return
04:25pm, Friday, 22'nd Oct 2021
Geron has seen some favorable Phase II data from their core product pipeline, which helped drive their share price up by ~20% over the past few months.
Geron Announces Completion of Patient Enrollment in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
07:30am, Monday, 18'th Oct 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignanci
Geron to Host a Virtual Investor Event in November
04:05pm, Friday, 15'th Oct 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron to Host a Virtual Investor Event in November
GERN Stock: Why It Increased Today
11:21am, Tuesday, 12'th Oct 2021
The stock price of Geron Corporation (Nasdaq: GERN) increased by over 7% during intraday trading today. This is why it happened.
Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
04:30pm, Monday, 11'th Oct 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Announces Publication of Analyses Comparing Real World Data to IMbark Phase 2 in Annals of Hematology
Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Thursday, 16'th Sep 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 400,000 shares of Geron common stock
Geron Announces September Investor Conference Presentation Webcasts
04:30pm, Wednesday, 01'st Sep 2021
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., Geron's Chairman and Chief Executive Officer, is scheduled to present at the followi
Here's What Investors Need From Geron
08:01am, Saturday, 28'th Aug 2021
It could be a while before Geron has a big catalyst.
